Glaucoma Sensor

Glaucoma causes irreversible damage

Glaucoma is widespread. It is estimated that about 500,000 people suffer from glaucoma in Germany alone. Glaucoma causes irreversible damage to the nerve fibers of affected people and even leads to a complete loss of vision in about 10 percent of all people affected.

Timely treatment can reliably prevent permanent damage in most cases. Early diagnosis is therefore essential, which is why the necessary examinations should not be left out.

The influence of genes on the risk of glaucoma

Glaucoma develops slowly and is not noticed by those affected for a long time. By the time vision is noticeably impaired, the majority of existing photoreceptors are permanently destroyed.

It is now known that a particular gene has a decisive influence on the probability of developing glaucoma. A genetic test can, therefore, help to identify individual risks and, if necessary, arrange for appropriate eye examinations.

This is how the Glaucoma Sensor works

As part of the Glaucoma Sensor, we analyze the sample sent in in our laboratory. We investigate the LOXL1 gene relevant to glaucoma. In addition, we are investigating whether the genetic profile influences the effect and tolerability of 17 relevant drugs.

In this way, we can determine the patient’s genetic glaucoma risk and whether a detailed examination of the eyes is appropriate.

After the successful completion of the analysis, we prepare a clear, written evaluation. In this, we present our results in detail.

Thus, our Glaucoma Sensor can make an important contribution to the early detection of glaucoma and help to prevent permanent eye damage with the right preventive measures.

The Glaucoma Sensor at a glance:

• Analysis of the gene relevant for glaucoma
• Evaluation of the individual glaucoma risk
• Evaluation of the effect of 17 drugs based on the gene profile
• Reliable testing by our laboratory
• Written report with all results
• Concrete recommendations for action based on the test results